How drugs like Ozempic are revolutionizing kidney treatment

AI Briefing

• – Ozempic is being used off-label to treat non-alcoholic steatohepatitis (NASH) and may help slow kidney damage.
• – Sotagliflozin, a medication used to treat type 1 diabetes, is being studied for its potential to reduce kidney damage in patients with type 2 diabetes.
• – New medications like Lixilvi and Farxiga are also being explored for their ability to slow kidney damage and improve outcomes in patients with chronic kidney disease.